• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Roy D. Baynes - Articles and news items

Gilead logo

Gilead announces response data from Phase 2 study of idelalisib for previously untreated CLL

Industry news, News / 15 May 2013 / Gilead Sciences

Gilead Sciences, Inc. announced results from a Phase 2 study…

Gilead logo

Gilead initiates Phase 3 clinical trial evaluating GS-1101 for the treatment of chronic lymphocytic leukemia

Industry news, News / 1 May 2012 / Gilead Sciences

Gilead Sciences announced that the first patient has been dosed in a Phase 3 clinical trial…

Gilead logo

Roy D. Baynes, MD, PhD, to join Gilead Sciences as Senior Vice President, Oncology Therapeutics

Industry news, News / 18 January 2012 / Gilead Sciences

Gilead Sciences, Inc. announced that Roy D. Baynes, MD, PhD, will join the company…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +